Identification of Filamin-A and -B As Potential Biomarkers for Prostate Cancer

References

• Alberts AR, Schoots IG, Roobol MJ. Prostate-specific antigen-based prostate cancer screening: past and future. Int. J. Urol. 22(6), 524–532 (2015).
   PubMed Web of Science ®Google Scholar
• Gardiner RA, Chambers SK, Williams SG, Yaxley J, Samaratunga H, Frydenberg M. Prostate cancer – part one: detection. In: Endotext. De Groot LJ, Beck-Peccoz P, Chrousos G et al. Eds). South Dartmouth, MA, USA (2000).
   Google Scholar
• Moyer VA, Force USPST. Screening for prostate cancer: US Preventive Services Task Force recommendation statement. Ann. Intern. Med. 157(2), 120–134 (2012).
   PubMed Web of Science ®Google Scholar
• Shtivelman E, Beer TM, Evans CP. Molecular pathways and targets in prostate cancer. Oncotarget 5(17), 7217–7259 (2014).
   PubMed Web of Science ®Google Scholar
• Tjalsma H, Bolhuis A, Jongbloed JD, Bron S, Van Dijl JM. Signal peptide-dependent protein transport in Bacillus subtilis: a genome-based survey of the secretome. Microbiol. Mol. Biol. Rev. 64(3), 515–547 (2000).
   PubMed Web of Science ®Google Scholar
• Ross PL, Huang YN, Marchese JN et al. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol. Cell. Proteomics 3(12), 1154–1169 (2004).
   PubMed Web of Science ®Google Scholar
• Pearl J. Causality, Reasoning and Inference. Cambridge University Press, NY, USA. (2000).
   Google Scholar
• Xing H, Mcdonagh PD, Bienkowska J et al. Causal modeling using network ensemble simulations of genetic and gene expression data predicts genes involved in rheumatoid arthritis. PLoS Comput. Biol. 7(3), e1001105 (2011).
   PubMed Web of Science ®Google Scholar
• Burt R, Xa S. Structural holes and good ideas. Am. J. Soc. 110(2), 349–399 (2004).
   Web of Science ®Google Scholar
• Yang W, Zou L, Huang C, Lei Y. Redox regulation of cancer metastasis: molecular signaling and therapeutic opportunities. Drug Dev. Res. 75(5), 331–341 (2014).
   PubMed Web of Science ®Google Scholar
• Zhang S, Yang C, Yang Z et al. Homeostasis of redox status derived from glucose metabolic pathway could be the key to understanding the Warburg effect. Am. J. Cancer Res. 5(3), 928–944 (2015).
   PubMed Web of Science ®Google Scholar
• Baldassarre M, Razinia Z, Burande CF, Lamsoul I, Lutz PG, Calderwood DA. Filamins regulate cell spreading and initiation of cell migration. PLoS ONE 4(11), e7830 (2009).
   PubMed Web of Science ®Google Scholar
• Bedolla RG, Wang Y, Asuncion A et al. Nuclear versus cytoplasmic localization of filamin A in prostate cancer: immunohistochemical correlation with metastases. Clin. Cancer Res. 15(3), 788–796 (2009).
   PubMed Web of Science ®Google Scholar
• Sun GG, Lu YF, Zhang J, Hu WN. Filamin A regulates MMP-9 expression and suppresses prostate cancer cell migration and invasion. Tumour Biol. 35(4), 3819–3826 (2014).
   PubMedGoogle Scholar
• Anastasiadis AG, Stisser BC, Ghafar MA, Burchardt M, Buttyan R. Tumor hypoxia and the progression of prostate cancer. Curr. Urol. Rep. 3(3), 222–228 (2002).
   PubMedGoogle Scholar
• De Marzo AM, Platz EA, Sutcliffe S et al. Inflammation in prostate carcinogenesis. Nat. Rev. Cancer 7(4), 256–269 (2007).
   PubMed Web of Science ®Google Scholar
• Lee HY, Yang EG, Park H. Hypoxia enhances the expression of prostate-specific antigen by modifying the quantity and catalytic activity of Jumonji C domain-containing histone demethylases. Carcinogenesis 34(12), 2706–2715 (2013).
   PubMed Web of Science ®Google Scholar
• Mizokami A, Gotoh A, Yamada H, Keller ET, Matsumoto T. Tumor necrosis factor-alpha represses androgen sensitivity in the LNCaP prostate cancer cell line. J. Urol. 164(3 Pt 1), 800–805 (2000).
   PubMed Web of Science ®Google Scholar
• Debelec-Butuner B, Alapinar C, Varisli L et al. Inflammation-mediated abrogation of androgen signaling: an in vitro model of prostate cell inflammation. Mol. Carcinog. 53(2), 85–97 (2014).
   PubMed Web of Science ®Google Scholar
• Lilja H. Biology of prostate-specific antigen. Urology 62(5 Suppl. 1), 27–33 (2003).
   PubMedGoogle Scholar
• Lancashire LJ, Lemetre C, Ball GR. An introduction to artificial neural networks in bioinformatics-application to complex microarray and mass spectrometry datasets in cancer studies. Brief. Bioinform. 10(3), 315–329 (2009).
   PubMed Web of Science ®Google Scholar
• Mendez O, Villanueva J. Challenges and opportunities for cell line secretomes in cancer proteomics. Proteomics Clin. Appl. 9(3–4), 348–357 (2015).
   PubMed Web of Science ®Google Scholar
• Paltridge JL, Belle L, Khew-Goodall Y. The secretome in cancer progression. Biochim. Biophys. Acta 1834(11), 2233–2241 (2013).
   PubMed Web of Science ®Google Scholar
• Jurado J, Fuentes-Almagro CA, Guardiola FA, Cuesta A, Esteban MA, Prieto-Alamo MJ. Proteomic profile of the skin mucus of farmed gilthead seabream (Sparus aurata). J. Proteomics 120, 21–34 (2015).
   PubMed Web of Science ®Google Scholar
• Delbosc S, Haloui M, Louedec L et al. Proteomic analysis permits the identification of new biomarkers of arterial wall remodeling in hypertension. Mol. Med. 14(7–8), 383–394 (2008).
   PubMed Web of Science ®Google Scholar
• Anti-FLNA Antibody (HPA004747). https://atlasantibodiescom/#!/products/FLNB-antibody-HPA004747
   Google Scholar
• Guzvic M, Braun B, Ganzer R et al. Combined genome and transcriptome analysis of single disseminated cancer cells from bone marrow of prostate cancer patients reveals unexpected transcriptomes. Cancer Res. 74(24), 7383–7394 (2014).
   PubMed Web of Science ®Google Scholar
• Amaro A, Esposito AI, Gallina A et al. Validation of proposed prostate cancer biomarkers with gene expression data: a long road to travel. Cancer Metastasis Rev. 33(2–3), 657–671 (2014).
   PubMed Web of Science ®Google Scholar
• Loy CJ, Sim KS, Yong EL. Filamin-A fragment localizes to the nucleus to regulate androgen receptor and coactivator functions. Proc. Natl Acad. Sci. USA 100(8), 4562–4567 (2003).
   PubMed Web of Science ®Google Scholar
• Bandaru S, Zhou AX, Rouhi P et al. Targeting filamin B induces tumor growth and metastasis via enhanced activity of matrix metalloproteinase-9 and secretion of VEGF-A. Oncogenesis 3, e119 (2014).
   PubMed Web of Science ®Google Scholar
• Tian HM, Liu XH, Han W, Zhao LL, Yuan B, Yuan CJ. Differential expression of filamin A and its clinical significance in breast cancer. Oncol. Lett. 6(3), 681–686 (2013).
   PubMed Web of Science ®Google Scholar
• Li C, Yu S, Nakamura F et al. Binding of pro-prion to filamin A disrupts cytoskeleton and correlates with poor prognosis in pancreatic cancer. J. Clin. Invest. 119(9), 2725–2736 (2009).
   PubMed Web of Science ®Google Scholar
• Sartori DA, Chan DW. Biomarkers in prostate cancer: what’s new? Curr. Opin. Oncol. 26(3), 259–264 (2014).
   PubMed Web of Science ®Google Scholar